Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- Tacconelli, Evelina
- CARRARA, ELENA
- Savoldi, Alessia
- Harbarth, Stephan
- Mendelson, Marc
- Monnet, Dominique L
- Pulcini, Céline
- Kahlmeter, Gunnar
- Kluytmans, Jan
- Carmeli, Yehuda
- Ouellette, Marc
- Outterson, Kevin
- Patel, Jean
- Cavaleri, Marco
- Cox, Edward M
- Houchens, Chris R
- Grayson, M Lindsay
- Hansen, Paul
- Singh, Nalini
- Theuretzbacher, Ursula
- Magrini, Nicola
DOIAbstract
The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide. Due to its large public health and societal implications, multidrug-resistant tuberculosis has been long regarded by WHO as a global priority for investment in new drugs. In 2016, WHO was requested by member states to create a priority list of other antibiotic-resistant bacteria to support research and development of effective drugs
Add to ORKG